MedTrace Logo

Feasibility of RUS Lung in MITS

NCT06952894 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2025-09-03

No results posted yet for this study

Summary

This sponsor-initiated prospective observational study aims to demonstrate the feasibility and efficacy of RUS Lung Surgical Navigation System in patients undergoing minimally invasive thoracic surgery(MITS). The trial will enroll 36 patients who undergo video-assisted or robot-assisted thoracoscopic surgery using RUS Lung. The study will be conducted across two medical centers."

* Investigational Medical Device: RUS Lung (Endoscopic Imaging Treatment Planning Software)
* Clinical Trial duration: 12 months from IRB approval
* Target number of subjects: Total of 36 participants

Conditions

Interventions

DEVICE

RUS Lung

The RUS Lung is an endoscopic imaging treatment planning software program. It creates a patient-specific simulation of the thoracic surgical environments, allowing for the visualization of tumor, bronchovascular structures and thoracic organs during the surgical planning process and the operation. RUS Lung utilizes preoperative CT images of the patients to segment tumor, organs, blood vessels, and bronchus and reconstructs them into a 3D model. Although there is no direct intervention on the patient, the surgeon uses RUS Lung as a surgical navigation tool to simulate the surgery before performing the actual procedure.

Sponsors & Collaborators

  • Severance Hospital

    collaborator OTHER

  • Ajou University School of Medicine

    collaborator OTHER

  • Hutom Corp

    lead INDUSTRY

Principal Investigators

  • Chang Young Lee, M.D.,Ph.D. · Severance Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-12
Primary Completion
2025-05-28
Completion
2025-08-11

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06952894 on ClinicalTrials.gov